Federated Hermes, Inc. Poly Pid Ltd. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.92 - $6.25 $78,400 - $125,000	-20,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.52 - $8.42 $9,969 - $15,206	1,806 Added 9.93%	20,000 $115,000
Q2 2021 Aug 16, 2021	SELL	$8.4 - $9.99 $101,892 - $121,178	-12,130 Reduced 40.0%	18,194 $165,000
Q4 2020 Feb 12, 2021	SELL	$8.89 - $13.5 $130,469 - $198,126	-14,676 Reduced 32.61%	30,324 $302,000
Q3 2020 Nov 12, 2020	BUY	$11.0 - $17.33 $495,000 - $779,849	45,000 New	45,000 $495,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $64.5M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.